Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Dennis Lee Kasper, M.D.

TitleWilliam Ellery Channing Professor of Medicine
InstitutionHarvard Medical School
DepartmentMedicine
AddressHarvard Medical School
Microbiology and Immunobiology, 1056C
77 Avenue Louis Pasteur
Boston MA 02115
Phone617/432-5505
Fax617/432-5513
Other Positions
TitleProfessor of Microbiology and Immunobiology
InstitutionBrigham and Women's Hospital
DepartmentMicrobiology and Immunobiology
DivisionImmunology


 Mentoring 
 completed student projects
Colonic IL-1R1-Expressing Lymphoid Tissue Inducer-Like Cells are Innate IL-22 Producers
Summer, 06/21/10 - 08/14/10
Role of gamma-delta T cells in inflammatory bowel disease
Summer, 05/24/10 - 08/31/10

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. An D, Oh SF, Olszak T, Neves JF, Avci FY, Erturk-Hasdemir D, Lu X, Zeissig S, Blumberg RS, Kasper DL. Sphingolipids from a symbiotic microbe regulate homeostasis of host intestinal natural killer T cells. Cell. 2014 Jan 16; 156(1-2):123-33.
    View in: PubMed
  2. Dasgupta S, Kasper DL. Relevance of commensal microbiota in the treatment and prevention of inflammatory bowel disease. Inflamm Bowel Dis. 2013 Oct; 19(11):2478-89.
    View in: PubMed
  3. Chen VL, Avci FY, Kasper DL. A maternal vaccine against group B Streptococcus: Past, present, and future. Vaccine. 2013 Aug 28; 31 Suppl 4:D13-9.
    View in: PubMed
  4. An D, Kasper DL. Testosterone: more than having the guts to win the tour de france. Immunity. 2013 Aug 22; 39(2):208-10.
    View in: PubMed
  5. Erturk-Hasdemir D, Kasper DL. Resident commensals shaping immunity. Curr Opin Immunol. 2013 Aug; 25(4):450-5.
    View in: PubMed
  6. Okan NA, Kasper DL. The atypical lipopolysaccharide ofFrancisella. Carbohydr Res. 2013 Aug 30; 378:79-83.
    View in: PubMed
  7. Avci FY, Li X, Tsuji M, Kasper DL. Carbohydrates and T cells: A sweet twosome. Semin Immunol. 2013 Apr; 25(2):146-51.
    View in: PubMed
  8. Chen VL, Surana NK, Duan J, Kasper DL. Role of murine intestinal interleukin-1 receptor 1-expressing lymphoid tissue inducer-like cells in salmonella infection. PLoS One. 2013; 8(6):e65405.
    View in: PubMed
  9. Dasgupta S, Kasper DL. Traffic control at the "Gut-GALT crossroads". Cell Res. 2013 May; 23(5):590-1.
    View in: PubMed
  10. Mao YK, Kasper DL, Wang B, Forsythe P, Bienenstock J, Kunze WA. Bacteroides fragilis polysaccharide A is necessary and sufficient for acute activation of intestinal sensory neurons. Nat Commun. 2013 Feb 12; 4:1465.
    View in: PubMed
  11. Okan NA, Chalabaev S, Kim TH, Fink A, Ross RA, Kasper DL. Kdo Hydrolase Is Required for Francisella tularensis Virulence and Evasion of TLR2-Mediated Innate Immunity. MBio. 2013; 4(1).
    View in: PubMed
  12. Avci FY, Li X, Tsuji M, Kasper DL. Isolation of carbohydrate-specific CD4(+) T cell clones from mice after stimulation by two model glycoconjugate vaccines. Nat Protoc. 2012 Nov 29; 7(12):2180-92.
    View in: PubMed
  13. Chung H, Pamp SJ, Hill JA, Surana NK, Edelman SM, Troy EB, Reading NC, Villablanca EJ, Wang S, Mora JR, Umesaki Y, Mathis D, Benoist C, Relman DA, Kasper DL. Gut immune maturation depends on colonization with a host-specific microbiota. Cell. 2012 Jun 22; 149(7):1578-93.
    View in: PubMed
  14. Olszak T, An D, Zeissig S, Vera MP, Richter J, Franke A, Glickman JN, Siebert R, Baron RM, Kasper DL, Blumberg RS. Microbial exposure during early life has persistent effects on natural killer T cell function. Science. 2012 Apr 27; 336(6080):489-93.
    View in: PubMed
  15. Surana NK, Kasper DL. The yin yang of bacterial polysaccharides: lessons learned from B. fragilis PSA. Immunol Rev. 2012 Jan; 245(1):13-26.
    View in: PubMed
  16. Avci FY, Li X, Tsuji M, Kasper DL. A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design. Nat Med. 2011 Dec; 17(12):1602-9.
    View in: PubMed
  17. Kim TH, Pinkham JT, Heninger SJ, Chalabaev S, Kasper DL. Genetic modification of the O-polysaccharide of Francisella tularensis results in an avirulent live attenuated vaccine. J Infect Dis. 2012 Apr 1; 205(7):1056-65.
    View in: PubMed
  18. Cohen-Poradosu R, McLoughlin RM, Lee JC, Kasper DL. Bacteroides fragilis-stimulated interleukin-10 contains expanding disease. J Infect Dis. 2011 Aug 1; 204(3):363-71.
    View in: PubMed
  19. Reading NC, Kasper DL. The starting lineup: key microbial players in intestinal immunity and homeostasis. Front Microbiol. 2011; 2:148.
    View in: PubMed
  20. Duan J, Kasper DL. Regulation of T cells by gut commensal microbiota. Curr Opin Rheumatol. 2011 Jul; 23(4):372-6.
    View in: PubMed
  21. Chalabaev S, Anderson CA, Onderdonk AB, Kasper DL. Sensitivity of Francisella tularensis to ultrapure water and deoxycholate: implications for bacterial intracellular growth assay in macrophages. J Microbiol Methods. 2011 Jun; 85(3):230-2.
    View in: PubMed
  22. Duan J, Kasper DL. Oxidative depolymerization of polysaccharides by reactive oxygen/nitrogen species. Glycobiology. 2011 Apr; 21(4):401-9.
    View in: PubMed
  23. An D, Na C, Bielawski J, Hannun YA, Kasper DL. Membrane sphingolipids as essential molecular signals for Bacteroides survival in the intestine. Proc Natl Acad Sci U S A. 2011 Mar 15; 108 Suppl 1:4666-71.
    View in: PubMed
  24. Ochoa-Repáraz J, Mielcarz DW, Ditrio LE, Burroughs AR, Begum-Haque S, Dasgupta S, Kasper DL, Kasper LH. Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression. J Immunol. 2010 Oct 1; 185(7):4101-8.
    View in: PubMed
  25. McDonnell M, Liang Y, Noronha A, Coukos J, Kasper DL, Farraye FA, Ganley-Leal LM. Systemic Toll-like receptor ligands modify B-cell responses in human inflammatory bowel disease. Inflamm Bowel Dis. 2011 Jan; 17(1):298-307.
    View in: PubMed
  26. Chalabaev S, Kim TH, Ross R, Derian A, Kasper DL. 3-Deoxy-D-manno-octulosonic acid (Kdo) hydrolase identified in Francisella tularensis, Helicobacter pylori, and Legionella pneumophila. J Biol Chem. 2010 Nov 5; 285(45):34330-6.
    View in: PubMed
  27. Troy EB, Carey VJ, Kasper DL, Comstock LE. Orientations of the Bacteroides fragilis capsular polysaccharide biosynthesis locus promoters during symbiosis and infection. J Bacteriol. 2010 Nov; 192(21):5832-6.
    View in: PubMed
  28. Chung H, Kasper DL. Microbiota-stimulated immune mechanisms to maintain gut homeostasis. Curr Opin Immunol. 2010 Aug; 22(4):455-60.
    View in: PubMed
  29. Kim TH, Sebastian S, Pinkham JT, Ross RA, Blalock LT, Kasper DL. Characterization of the O-antigen polymerase (Wzy) of Francisella tularensis. J Biol Chem. 2010 Sep 3; 285(36):27839-49.
    View in: PubMed
  30. Ochoa-Repáraz J, Mielcarz DW, Wang Y, Begum-Haque S, Dasgupta S, Kasper DL, Kasper LH. A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease. Mucosal Immunol. 2010 Sep; 3(5):487-95.
    View in: PubMed
  31. Duan J, Chung H, Troy E, Kasper DL. Microbial colonization drives expansion of IL-1 receptor 1-expressing and IL-17-producing gamma/delta T cells. Cell Host Microbe. 2010 Feb 18; 7(2):140-50.
    View in: PubMed
  32. Avci FY, Kasper DL. How bacterial carbohydrates influence the adaptive immune system. Annu Rev Immunol. 2010; 28:107-30.
    View in: PubMed
  33. Dasgupta S, Kasper DL. Novel tools for modulating immune responses in the host-polysaccharides from the capsule of commensal bacteria. Adv Immunol. 2010; 106:61-91.
    View in: PubMed
  34. Troy EB, Kasper DL. Beneficial effects of Bacteroides fragilis polysaccharides on the immune system. Front Biosci. 2010; 15:25-34.
    View in: PubMed
  35. Charity JC, Blalock LT, Costante-Hamm MM, Kasper DL, Dove SL. Small molecule control of virulence gene expression in Francisella tularensis. PLoS Pathog. 2009 Oct; 5(10):e1000641.
    View in: PubMed
  36. Kasper DL. A paradigm for commensalism: the role of a specific microbial polysaccharide in health and disease. Nestle Nutr Workshop Ser Pediatr Program. 2009; 64:1-8; discussion 8-10, 251-7.
    View in: PubMed
  37. Velez CD, Lewis CJ, Kasper DL, Cobb BA. Type I Streptococcus pneumoniae carbohydrate utilizes a nitric oxide and MHC II-dependent pathway for antigen presentation. Immunology. 2009 May; 127(1):73-82.
    View in: PubMed
  38. Charrel-Dennis M, Latz E, Halmen KA, Trieu-Cuot P, Fitzgerald KA, Kasper DL, Golenbock DT. TLR-independent type I interferon induction in response to an extracellular bacterial pathogen via intracellular recognition of its DNA. Cell Host Microbe. 2008 Dec 11; 4(6):543-54.
    View in: PubMed
  39. Sebastian S, Pinkham JT, Lynch JG, Ross RA, Reinap B, Blalock LT, Conlan JW, Kasper DL. Cellular and humoral immunity are synergistic in protection against types A and B Francisella tularensis. Vaccine. 2009 Jan 22; 27(4):597-605.
    View in: PubMed
  40. Guttormsen HK, Stuart LM, Shi L, Carroll MC, Chen J, Kasper DL, Ezekowitz RA, Takahashi K. Deficiency of mannose-binding lectin greatly increases antibody response in a mouse model of vaccination. Clin Immunol. 2009 Mar; 130(3):264-71.
    View in: PubMed
  41. Edelman SM, Kasper DL. Symbiotic commensal bacteria direct maturation of the host immune system. Curr Opin Gastroenterol. 2008 Nov; 24(6):720-4.
    View in: PubMed
  42. McLoughlin RM, Lee JC, Kasper DL, Tzianabos AO. IFN-gamma regulated chemokine production determines the outcome of Staphylococcus aureus infection. J Immunol. 2008 Jul 15; 181(2):1323-32.
    View in: PubMed
  43. Cobb BA, Kasper DL. Characteristics of carbohydrate antigen binding to the presentation protein HLA-DR. Glycobiology. 2008 Sep; 18(9):707-18.
    View in: PubMed
  44. Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature. 2008 May 29; 453(7195):620-5.
    View in: PubMed
  45. Duan J, Avci FY, Kasper DL. Microbial carbohydrate depolymerization by antigen-presenting cells: deamination prior to presentation by the MHCII pathway. Proc Natl Acad Sci U S A. 2008 Apr 1; 105(13):5183-8.
    View in: PubMed
  46. Guttormsen HK, Paoletti LC, Mansfield KG, Jachymek W, Jennings HJ, Kasper DL. Rational chemical design of the carbohydrate in a glycoconjugate vaccine enhances IgM-to-IgG switching. Proc Natl Acad Sci U S A. 2008 Apr 15; 105(15):5903-8.
    View in: PubMed
  47. Liu CH, Lee SM, Vanlare JM, Kasper DL, Mazmanian SK. Regulation of surface architecture by symbiotic bacteria mediates host colonization. Proc Natl Acad Sci U S A. 2008 Mar 11; 105(10):3951-6.
    View in: PubMed
  48. Cohen-Poradosu R, Kasper DL. Group A streptococcus epidemiology and vaccine implications. Clin Infect Dis. 2007 Oct 1; 45(7):863-5.
    View in: PubMed
  49. Sebastian S, Dillon ST, Lynch JG, Blalock LT, Balon E, Lee KT, Comstock LE, Conlan JW, Rubin EJ, Tzianabos AO, Kasper DL. A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity. Infect Immun. 2007 May; 75(5):2591-602.
    View in: PubMed
  50. Wang Q, McLoughlin RM, Cobb BA, Charrel-Dennis M, Zaleski KJ, Golenbock D, Tzianabos AO, Kasper DL. A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2. J Exp Med. 2006 Dec 25; 203(13):2853-63.
    View in: PubMed
  51. Mazmanian SK, Kasper DL. The love-hate relationship between bacterial polysaccharides and the host immune system. Nat Rev Immunol. 2006 Nov; 6(11):849-58.
    View in: PubMed
  52. Comstock LE, Kasper DL. Bacterial glycans: key mediators of diverse host immune responses. Cell. 2006 Sep 8; 126(5):847-50.
    View in: PubMed
  53. Lehnardt S, Henneke P, Lien E, Kasper DL, Volpe JJ, Bechmann I, Nitsch R, Weber JR, Golenbock DT, Vartanian T. A mechanism for neurodegeneration induced by group B streptococci through activation of the TLR2/MyD88 pathway in microglia. J Immunol. 2006 Jul 1; 177(1):583-92.
    View in: PubMed
  54. Ruiz-Perez B, Chung DR, Sharpe AH, Yagita H, Kalka-Moll WM, Sayegh MH, Kasper DL, Tzianabos AO. Modulation of surgical fibrosis by microbial zwitterionic polysaccharides. Proc Natl Acad Sci U S A. 2005 Nov 15; 102(46):16753-8.
    View in: PubMed
  55. Cobb BA, Kasper DL. Zwitterionic capsular polysaccharides: the new MHCII-dependent antigens. Cell Microbiol. 2005 Oct; 7(10):1398-403.
    View in: PubMed
  56. Tettelin H, Masignani V, Cieslewicz MJ, Donati C, Medini D, Ward NL, Angiuoli SV, Crabtree J, Jones AL, Durkin AS, Deboy RT, Davidsen TM, Mora M, Scarselli M, Margarit y Ros I, Peterson JD, Hauser CR, Sundaram JP, Nelson WC, Madupu R, Brinkac LM, Dodson RJ, Rosovitz MJ, Sullivan SA, Daugherty SC, Haft DH, Selengut J, Gwinn ML, Zhou L, Zafar N, Khouri H, Radune D, Dimitrov G, Watkins K, O'Connor KJ, Smith S, Utterback TR, White O, Rubens CE, Grandi G, Madoff LC, Kasper DL, Telford JL, Wessels MR, Rappuoli R, Fraser CM. Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome". Proc Natl Acad Sci U S A. 2005 Sep 27; 102(39):13950-5.
    View in: PubMed
  57. Baron MJ, Kasper DL. Anchors away: contribution of a glycolipid anchor to bacterial invasion of host cells. J Clin Invest. 2005 Sep; 115(9):2325-7.
    View in: PubMed
  58. Kasper DL, Sahani D, Misdraji J. Case records of the Massachusetts General Hospital. Case 25-2005. A 40-year-old man with prolonged fever and weight loss. N Engl J Med. 2005 Aug 18; 353(7):713-22.
    View in: PubMed
  59. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell. 2005 Jul 15; 122(1):107-18.
    View in: PubMed
  60. Maione D, Margarit I, Rinaudo CD, Masignani V, Mora M, Scarselli M, Tettelin H, Brettoni C, Iacobini ET, Rosini R, D'Agostino N, Miorin L, Buccato S, Mariani M, Galli G, Nogarotto R, Nardi Dei V, Vegni F, Fraser C, Mancuso G, Teti G, Madoff LC, Paoletti LC, Rappuoli R, Kasper DL, Telford JL, Grandi G. Identification of a universal Group B streptococcus vaccine by multiple genome screen. Science. 2005 Jul 1; 309(5731):148-50.
    View in: PubMed
  61. Henneke P, Morath S, Uematsu S, Weichert S, Pfitzenmaier M, Takeuchi O, Müller A, Poyart C, Akira S, Berner R, Teti G, Geyer A, Hartung T, Trieu-Cuot P, Kasper DL, Golenbock DT. Role of lipoteichoic acid in the phagocyte response to group B streptococcus. J Immunol. 2005 May 15; 174(10):6449-55.
    View in: PubMed
  62. Cieslewicz MJ, Chaffin D, Glusman G, Kasper D, Madan A, Rodrigues S, Fahey J, Wessels MR, Rubens CE. Structural and genetic diversity of group B streptococcus capsular polysaccharides. Infect Immun. 2005 May; 73(5):3096-103.
    View in: PubMed
  63. Stephen TL, Niemeyer M, Tzianabos AO, Kroenke M, Kasper DL, Kalka-Moll WM. Effect of B7-2 and CD40 signals from activated antigen-presenting cells on the ability of zwitterionic polysaccharides to induce T-Cell stimulation. Infect Immun. 2005 Apr; 73(4):2184-9.
    View in: PubMed
  64. Jiang SM, Cieslewicz MJ, Kasper DL, Wessels MR. Regulation of virulence by a two-component system in group B streptococcus. J Bacteriol. 2005 Feb; 187(3):1105-13.
    View in: PubMed
  65. Cobb BA, Kasper DL. Coming of age: carbohydrates and immunity. Eur J Immunol. 2005 Feb; 35(2):352-6.
    View in: PubMed
  66. Bartlett JG, Onderdonk AB, Cisneros RL, Kasper DL. Commentary: Bartlett JG, Onderdonk AB, Cisneros RL, Kasper DL. Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J Infect Dis 1977; 136:701. J Infect Dis. 2004 Jul 1; 190(1):202-9.
    View in: PubMed
  67. Cobb BA, Wang Q, Tzianabos AO, Kasper DL. Polysaccharide processing and presentation by the MHCII pathway. Cell. 2004 May 28; 117(5):677-87.
    View in: PubMed
  68. Baker CJ, Paoletti LC, Rench MA, Guttormsen HK, Edwards MS, Kasper DL. Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines. J Infect Dis. 2004 Mar 15; 189(6):1103-12.
    View in: PubMed
  69. Stingele F, Corthésy B, Kusy N, Porcelli SA, Kasper DL, Tzianabos AO. Zwitterionic polysaccharides stimulate T cells with no preferential V beta usage and promote anergy, resulting in protection against experimental abscess formation. J Immunol. 2004 Feb 1; 172(3):1483-90.
    View in: PubMed
  70. Tzianabos A, Wang JY, Kasper DL. Biological chemistry of immunomodulation by zwitterionic polysaccharides. Carbohydr Res. 2003 Nov 14; 338(23):2531-8.
    View in: PubMed
  71. Paoletti LC, Kasper DL. Glycoconjugate vaccines to prevent group B streptococcal infections. Expert Opin Biol Ther. 2003 Sep; 3(6):975-84.
    View in: PubMed
  72. Baker CJ, Rench MA, Fernandez M, Paoletti LC, Kasper DL, Edwards MS. Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III. J Infect Dis. 2003 Jul 1; 188(1):66-73.
    View in: PubMed
  73. Wang JY, Chang AH, Guttormsen HK, Rosas AL, Kasper DL. Construction of designer glycoconjugate vaccines with size-specific oligosaccharide antigens and site-controlled coupling. Vaccine. 2003 Mar 7; 21(11-12):1112-7.
    View in: PubMed
  74. Chung DR, Kasper DL, Panzo RJ, Chitnis T, Grusby MJ, Sayegh MH, Tzianabos AO, Chtinis T. CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism. J Immunol. 2003 Feb 15; 170(4):1958-63.
    View in: PubMed
  75. Pozdnyakova O, Guttormsen HK, Lalani FN, Carroll MC, Kasper DL. Impaired antibody response to group B streptococcal type III capsular polysaccharide in C3- and complement receptor 2-deficient mice. J Immunol. 2003 Jan 1; 170(1):84-90.
    View in: PubMed
  76. Choi YH, Roehrl MH, Kasper DL, Wang JY. A unique structural pattern shared by T-cell-activating and abscess-regulating zwitterionic polysaccharides. Biochemistry. 2002 Dec 24; 41(51):15144-51.
    View in: PubMed
  77. Kalka-Moll WM, Tzianabos AO, Bryant PW, Niemeyer M, Ploegh HL, Kasper DL. Zwitterionic polysaccharides stimulate T cells by MHC class II-dependent interactions. J Immunol. 2002 Dec 1; 169(11):6149-53.
    View in: PubMed
  78. Henneke P, Takeuchi O, Malley R, Lien E, Ingalls RR, Freeman MW, Mayadas T, Nizet V, Akira S, Kasper DL, Golenbock DT. Cellular activation, phagocytosis, and bactericidal activity against group B streptococcus involve parallel myeloid differentiation factor 88-dependent and independent signaling pathways. J Immunol. 2002 Oct 1; 169(7):3970-7.
    View in: PubMed
  79. Tettelin H, Masignani V, Cieslewicz MJ, Eisen JA, Peterson S, Wessels MR, Paulsen IT, Nelson KE, Margarit I, Read TD, Madoff LC, Wolf AM, Beanan MJ, Brinkac LM, Daugherty SC, DeBoy RT, Durkin AS, Kolonay JF, Madupu R, Lewis MR, Radune D, Fedorova NB, Scanlan D, Khouri H, Mulligan S, Carty HA, Cline RT, Van Aken SE, Gill J, Scarselli M, Mora M, Iacobini ET, Brettoni C, Galli G, Mariani M, Vegni F, Maione D, Rinaudo D, Rappuoli R, Telford JL, Kasper DL, Grandi G, Fraser CM. Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae. Proc Natl Acad Sci U S A. 2002 Sep 17; 99(19):12391-6.
    View in: PubMed
  80. Paoletti LC, Kasper DL. Conjugate vaccines against group B Streptococcus types IV and VII. J Infect Dis. 2002 Jul 1; 186(1):123-6.
    View in: PubMed
  81. Chung DR, Chitnis T, Panzo RJ, Kasper DL, Sayegh MH, Tzianabos AO. CD4+ T cells regulate surgical and postinfectious adhesion formation. J Exp Med. 2002 Jun 3; 195(11):1471-8.
    View in: PubMed
  82. Brigtsen AK, Kasper DL, Baker CJ, Jennings HJ, Guttormsen HK. Induction of cross-reactive antibodies by immunization of healthy adults with types Ia and Ib group B streptococcal polysaccharide-tetanus toxoid conjugate vaccines. J Infect Dis. 2002 May 1; 185(9):1277-84.
    View in: PubMed
  83. Guttormsen HK, Baker CJ, Nahm MH, Paoletti LC, Zughaier SM, Edwards MS, Kasper DL. Type III group B streptococcal polysaccharide induces antibodies that cross-react with Streptococcus pneumoniae type 14. Infect Immun. 2002 Apr; 70(4):1724-38.
    View in: PubMed
  84. Tzianabos AO, Kasper DL. Role of T cells in abscess formation. Curr Opin Microbiol. 2002 Feb; 5(1):92-6.
    View in: PubMed
  85. Lachenauer CS, Baker CJ, Baron MJ, Kasper DL, Gravekamp C, Madoff LC. Quantitative determination of immunoglobulin G specific for group B streptococcal beta C protein in human maternal serum. J Infect Dis. 2002 Feb 1; 185(3):368-74.
    View in: PubMed
  86. Henneke P, Takeuchi O, van Strijp JA, Guttormsen HK, Smith JA, Schromm AB, Espevik TA, Akira S, Nizet V, Kasper DL, Golenbock DT. Novel engagement of CD14 and multiple toll-like receptors by group B streptococci. J Immunol. 2001 Dec 15; 167(12):7069-76.
    View in: PubMed
  87. Krinos CM, Coyne MJ, Weinacht KG, Tzianabos AO, Kasper DL, Comstock LE. Extensive surface diversity of a commensal microorganism by multiple DNA inversions. Nature. 2001 Nov 29; 414(6863):555-8.
    View in: PubMed
  88. Paoletti LC, Rench MA, Kasper DL, Molrine D, Ambrosino D, Baker CJ. Effects of alum adjuvant or a booster dose on immunogenicity during clinical trials of group B streptococcal type III conjugate vaccines. Infect Immun. 2001 Nov; 69(11):6696-701.
    View in: PubMed
  89. Coyne MJ, Tzianabos AO, Mallory BC, Carey VJ, Kasper DL, Comstock LE. Polysaccharide biosynthesis locus required for virulence of Bacteroides fragilis. Infect Immun. 2001 Jul; 69(7):4342-50.
    View in: PubMed
  90. Nielsen MS, Madsen P, Christensen EI, Nykjaer A, Gliemann J, Kasper D, Pohlmann R, Petersen CM. The sortilin cytoplasmic tail conveys Golgi-endosome transport and binds the VHS domain of the GGA2 sorting protein. EMBO J. 2001 May 1; 20(9):2180-90.
    View in: PubMed
  91. Kalka-Moll WM, Wang Y, Comstock LE, Gonzalez SE, Tzianabos AO, Kasper DL. Immunochemical and biological characterization of three capsular polysaccharides from a single Bacteroides fragilis strain. Infect Immun. 2001 Apr; 69(4):2339-44.
    View in: PubMed
  92. Kornak U, Kasper D, Bösl MR, Kaiser E, Schweizer M, Schulz A, Friedrich W, Delling G, Jentsch TJ. Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell. 2001 Jan 26; 104(2):205-15.
    View in: PubMed
  93. Cieslewicz MJ, Kasper DL, Wang Y, Wessels MR. Functional analysis in type Ia group B Streptococcus of a cluster of genes involved in extracellular polysaccharide production by diverse species of streptococci. J Biol Chem. 2001 Jan 5; 276(1):139-46.
    View in: PubMed
  94. Wang Y, Kalka-Moll WM, Roehrl MH, Kasper DL. Structural basis of the abscess-modulating polysaccharide A2 from Bacteroides fragilis. Proc Natl Acad Sci U S A. 2000 Dec 5; 97(25):13478-83.
    View in: PubMed
  95. Martin JB, Kasper DL. In whose best interest? Breaching the academic-industrial wall. N Engl J Med. 2000 Nov 30; 343(22):1646-9.
    View in: PubMed
  96. Comstock LE, Pantosti A, Kasper DL. Genetic diversity of the capsular polysaccharide C biosynthesis region of Bacteroides fragilis. Infect Immun. 2000 Nov; 68(11):6182-8.
    View in: PubMed
  97. Coyne MJ, Kalka-Moll W, Tzianabos AO, Kasper DL, Comstock LE. Bacteroides fragilis NCTC9343 produces at least three distinct capsular polysaccharides: cloning, characterization, and reassignment of polysaccharide B and C biosynthesis loci. Infect Immun. 2000 Nov; 68(11):6176-81.
    View in: PubMed
  98. Greeve I, Hermans-Borgmeyer I, Brellinger C, Kasper D, Gomez-Isla T, Behl C, Levkau B, Nitsch RM. The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stress. J Neurosci. 2000 Oct 1; 20(19):7345-52.
    View in: PubMed
  99. Baker CJ, Paoletti LC, Rench MA, Guttormsen HK, Carey VJ, Hickman ME, Kasper DL. Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women. J Infect Dis. 2000 Oct; 182(4):1129-38.
    View in: PubMed
  100. Deng L, Kasper DL, Krick TP, Wessels MR. Characterization of the linkage between the type III capsular polysaccharide and the bacterial cell wall of group B Streptococcus. J Biol Chem. 2000 Mar 17; 275(11):7497-504.
    View in: PubMed
  101. Tzianabos AO, Finberg RW, Wang Y, Chan M, Onderdonk AB, Jennings HJ, Kasper DL. T cells activated by zwitterionic molecules prevent abscesses induced by pathogenic bacteria. J Biol Chem. 2000 Mar 10; 275(10):6733-40.
    View in: PubMed
  102. Paoletti LC, Pinel J, Kennedy RC, Kasper DL. Maternal antibody transfer in baboons and mice vaccinated with a group B streptococcal polysaccharide conjugate. J Infect Dis. 2000 Feb; 181(2):653-8.
    View in: PubMed
  103. Kalka-Moll WM, Tzianabos AO, Wang Y, Carey VJ, Finberg RW, Onderdonk AB, Kasper DL. Effect of molecular size on the ability of zwitterionic polysaccharides to stimulate cellular immunity. J Immunol. 2000 Jan 15; 164(2):719-24.
    View in: PubMed
  104. Guttormsen HK, Sharpe AH, Chandraker AK, Brigtsen AK, Sayegh MH, Kasper DL. Cognate stimulatory B-cell-T-cell interactions are critical for T-cell help recruited by glycoconjugate vaccines. Infect Immun. 1999 Dec; 67(12):6375-84.
    View in: PubMed
  105. Comstock LE, Coyne MJ, Tzianabos AO, Kasper DL. Interstrain variation of the polysaccharide B biosynthesis locus of Bacteroides fragilis: characterization of the region from strain 638R. J Bacteriol. 1999 Oct; 181(19):6192-6.
    View in: PubMed
  106. Paoletti LC, Pinel J, Johnson KD, Reinap B, Ross RA, Kasper DL. Synthesis and preclinical evaluation of glycoconjugate vaccines against group B Streptococcus types VI and VIII. J Infect Dis. 1999 Sep; 180(3):892-5.
    View in: PubMed
  107. Kasper DL, Wessels MR, Guttormsen HK, Paoletti LC, Edwards MS, Baker CJ. Measurement of human antibodies to type III group B Streptococcus. Infect Immun. 1999 Aug; 67(8):4303-5.
    View in: PubMed
  108. Tzianabos AO, Russell PR, Onderdonk AB, Gibson FC, Cywes C, Chan M, Finberg RW, Kasper DL. IL-2 mediates protection against abscess formation in an experimental model of sepsis. J Immunol. 1999 Jul 15; 163(2):893-7.
    View in: PubMed
  109. Comstock LE, Coyne MJ, Tzianabos AO, Pantosti A, Onderdonk AB, Kasper DL. Analysis of a capsular polysaccharide biosynthesis locus of Bacteroides fragilis. Infect Immun. 1999 Jul; 67(7):3525-32.
    View in: PubMed
  110. Wang Y, Hollingsworth RI, Kasper DL. Ozonolytic depolymerization of polysaccharides in aqueous solution. Carbohydr Res. 1999 Jun 30; 319(1-4):141-7.
    View in: PubMed
  111. Gravekamp C, Kasper DL, Paoletti LC, Madoff LC. Alpha C protein as a carrier for type III capsular polysaccharide and as a protective protein in group B streptococcal vaccines. Infect Immun. 1999 May; 67(5):2491-6.
    View in: PubMed
  112. Lachenauer CS, Kasper DL, Shimada J, Ichiman Y, Ohtsuka H, Kaku M, Paoletti LC, Ferrieri P, Madoff LC. Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women. J Infect Dis. 1999 Apr; 179(4):1030-3.
    View in: PubMed
  113. Wang Y, Huebner J, Tzianabos AO, Martirosian G, Kasper DL, Pier GB. Structure of an antigenic teichoic acid shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium. Carbohydr Res. 1999 Mar 31; 316(1-4):155-60.
    View in: PubMed
  114. Huebner J, Wang Y, Krueger WA, Madoff LC, Martirosian G, Boisot S, Goldmann DA, Kasper DL, Tzianabos AO, Pier GB. Isolation and chemical characterization of a capsular polysaccharide antigen shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium. Infect Immun. 1999 Mar; 67(3):1213-9.
    View in: PubMed
  115. Brubaker JO, Li Q, Tzianabos AO, Kasper DL, Finberg RW. Mitogenic activity of purified capsular polysaccharide A from Bacteroides fragilis: differential stimulatory effect on mouse and rat lymphocytes in vitro. J Immunol. 1999 Feb 15; 162(4):2235-42.
    View in: PubMed
  116. Baker CJ, Paoletti LC, Wessels MR, Guttormsen HK, Rench MA, Hickman ME, Kasper DL. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. J Infect Dis. 1999 Jan; 179(1):142-50.
    View in: PubMed
  117. Wessels MR, Kasper DL, Johnson KD, Harrison LH. Antibody responses in invasive group B streptococcal infection in adults. J Infect Dis. 1998 Aug; 178(2):569-72.
    View in: PubMed
  118. Tzianabos AO, Gibson FC, Cisneros RL, Kasper DL. Protection against experimental intraabdominal sepsis by two polysaccharide immunomodulators. J Infect Dis. 1998 Jul; 178(1):200-6.
    View in: PubMed
  119. Wang Y, Hollingsworth RI, Kasper DL. Ozonolysis for selectively depolymerizing polysaccharides containing beta-D-aldosidic linkages. Proc Natl Acad Sci U S A. 1998 Jun 9; 95(12):6584-9.
    View in: PubMed
  120. Gibson FC, Onderdonk AB, Kasper DL, Tzianabos AO. Cellular mechanism of intraabdominal abscess formation by Bacteroides fragilis. J Immunol. 1998 May 15; 160(10):5000-6.
    View in: PubMed
  121. Guttormsen HK, Wetzler LM, Finberg RW, Kasper DL. Immunologic memory induced by a glycoconjugate vaccine in a murine adoptive lymphocyte transfer model. Infect Immun. 1998 May; 66(5):2026-32.
    View in: PubMed
  122. Oken E, Kasper DL, Gleason RE, Adler GK. Tetanus toxoid stimulation of the hypothalamic-pituitary-adrenal axis correlates inversely with the increase in tetanus toxoid antibody titers. J Clin Endocrinol Metab. 1998 May; 83(5):1691-6.
    View in: PubMed
  123. Wessels MR, Paoletti LC, Guttormsen HK, Michon F, D'Ambra AJ, Kasper DL. Structural properties of group B streptococcal type III polysaccharide conjugate vaccines that influence immunogenicity and efficacy. Infect Immun. 1998 May; 66(5):2186-92.
    View in: PubMed
  124. Gravekamp C, Kasper DL, Michel JL, Kling DE, Carey V, Madoff LC. Immunogenicity and protective efficacy of the alpha C protein of group B streptococci are inversely related to the number of repeats. Infect Immun. 1997 Dec; 65(12):5216-21.
    View in: PubMed
  125. Li J, Kasper DL, Ausubel FM, Rosner B, Michel JL. Inactivation of the alpha C protein antigen gene, bca, by a novel shuttle/suicide vector results in attenuation of virulence and immunity in group B Streptococcus. Proc Natl Acad Sci U S A. 1997 Nov 25; 94(24):13251-6.
    View in: PubMed
  126. Paoletti LC, Pinel J, Rodewald AK, Kasper DL. Therapeutic potential of human antisera to group B streptococcal glycoconjugate vaccines in neonatal mice. J Infect Dis. 1997 May; 175(5):1237-9.
    View in: PubMed
  127. Brisson JR, Uhrinova S, Woods RJ, van der Zwan M, Jarrell HC, Paoletti LC, Kasper DL, Jennings HJ. NMR and molecular dynamics studies of the conformational epitope of the type III group B Streptococcus capsular polysaccharide and derivatives. Biochemistry. 1997 Mar 18; 36(11):3278-92.
    View in: PubMed
  128. Gravekamp C, Kasper DL, Madoff LC. Immunization with a single-repeat alpha C protein may prevent escape of lower repeat mutants of group B Streptococcus. Adv Exp Med Biol. 1997; 418:855-7.
    View in: PubMed
  129. Dale JB, Cleary PP, Fischetti VA, Kasper DL, Musser JM, Zabriskie JB. Group A and group B streptococcal vaccine development. A round table presentation. Adv Exp Med Biol. 1997; 418:863-8.
    View in: PubMed
  130. Kasper DL, Paoletti LC, Wessels MR, Guttormsen HK, Carey VJ, Jennings HJ, Baker CJ. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J Clin Invest. 1996 Nov 15; 98(10):2308-14.
    View in: PubMed
  131. Deresiewicz RL, Flaxenburg J, Leng K, Kasper DL. Sequence of the toxic shock syndrome toxin gene (tstH) borne by strains of Staphylococcus aureus isolated from patients with Kawasaki syndrome. Infect Immun. 1996 Aug; 64(8):3394-6.
    View in: PubMed
  132. Kasper D, Dittmer F, von Figura K, Pohlmann R. Neither type of mannose 6-phosphate receptor is sufficient for targeting of lysosomal enzymes along intracellular routes. J Cell Biol. 1996 Aug; 134(3):615-23.
    View in: PubMed
  133. Madoff LC, Michel JL, Gong EW, Kling DE, Kasper DL. Group B streptococci escape host immunity by deletion of tandem repeat elements of the alpha C protein. Proc Natl Acad Sci U S A. 1996 Apr 30; 93(9):4131-6.
    View in: PubMed
  134. Kogan G, Uhrín D, Brisson JR, Paoletti LC, Blodgett AE, Kasper DL, Jennings HJ. Structural and immunochemical characterization of the type VIII group B Streptococcus capsular polysaccharide. J Biol Chem. 1996 Apr 12; 271(15):8786-90.
    View in: PubMed
  135. Paoletti LC, Kennedy RC, Chanh TC, Kasper DL. Immunogenicity of group B Streptococcus type III polysaccharide-tetanus toxoid vaccine in baboons. Infect Immun. 1996 Feb; 64(2):677-9.
    View in: PubMed
  136. Guttormsen HK, Baker CJ, Edwards MS, Paoletti LC, Kasper DL. Quantitative determination of antibodies to type III group B streptococcal polysaccharide. J Infect Dis. 1996 Jan; 173(1):142-50.
    View in: PubMed
  137. Tzianabos AO, Kasper DL, Cisneros RL, Smith RS, Onderdonk AB. Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis. J Clin Invest. 1995 Dec; 96(6):2727-31.
    View in: PubMed
  138. Kogan G, Brisson JR, Kasper DL, von Hunolstein C, Orefici G, Jennings HJ. Structural elucidation of the novel type VII group B Streptococcus capsular polysaccharide by high resolution NMR spectroscopy. Carbohydr Res. 1995 Nov 7; 277(1):1-9.
    View in: PubMed
  139. Pavliak V, Uhrín D, Brisson JR, Tzianabos AO, Kasper DL, Jennings HJ. Structural elucidation of the capsular polysaccharide of Bacteroides fragilis strain 23745M1. Carbohydr Res. 1995 Oct 2; 275(2):333-41.
    View in: PubMed
  140. Pantosti A, Colangeli R, Tzianabos AO, Kasper DL. Monoclonal antibodies to detect capsular diversity among Bacteroides fragilis isolates. J Clin Microbiol. 1995 Oct; 33(10):2647-52.
    View in: PubMed
  141. Kasper DL. Designer vaccines to prevent infections due to group B Streptococcus. Proc Assoc Am Physicians. 1995 Oct; 107(3):369-73.
    View in: PubMed
  142. Tzianabos AO, Kasper DL, Onderdonk AB. Structure and function of Bacteroides fragilis capsular polysaccharides: relationship to induction and prevention of abscesses. Clin Infect Dis. 1995 Jun; 20 Suppl 2:S132-40.
    View in: PubMed
  143. Wessels MR, Paoletti LC, Pinel J, Kasper DL. Immunogenicity and protective activity in animals of a type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J Infect Dis. 1995 Apr; 171(4):879-84.
    View in: PubMed
  144. Tzianabos AO, Onderdonk AB, Zaleznik DF, Smith RS, Kasper DL. Structural characteristics of polysaccharides that induce protection against intra-abdominal abscess formation. Infect Immun. 1994 Nov; 62(11):4881-6.
    View in: PubMed
  145. Deresiewicz RL, Woo J, Chan M, Finberg RW, Kasper DL. Mutations affecting the activity of toxic shock syndrome toxin-1. Biochemistry. 1994 Nov 1; 33(43):12844-51.
    View in: PubMed
  146. Tzianabos AO, Onderdonk AB, Kasper DL. Bacterial structure and functional relation to abscess formation. Infect Agents Dis. 1994 Oct; 3(5):256-65.
    View in: PubMed
  147. Paoletti LC, Wessels MR, Rodewald AK, Shroff AA, Jennings HJ, Kasper DL. Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine. Infect Immun. 1994 Aug; 62(8):3236-43.
    View in: PubMed
  148. Tzianabos AO, Onderdonk AB, Smith RS, Kasper DL. Structure-function relationships for polysaccharide-induced intra-abdominal abscesses. Infect Immun. 1994 Aug; 62(8):3590-3.
    View in: PubMed
  149. Madoff LC, Paoletti LC, Tai JY, Kasper DL. Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes. J Clin Invest. 1994 Jul; 94(1):286-92.
    View in: PubMed
  150. Deresiewicz RL, Flaxenburg JA, Chan M, Finberg RW, Kasper DL. Intracellular expression of toxic shock syndrome toxin 1 in Saccharomyces cerevisiae. Infect Immun. 1994 Jun; 62(6):2202-7.
    View in: PubMed
  151. Marques MB, Kasper DL, Shroff A, Michon F, Jennings HJ, Wessels MR. Functional activity of antibodies to the group B polysaccharide of group B streptococci elicited by a polysaccharide-protein conjugate vaccine. Infect Immun. 1994 May; 62(5):1593-9.
    View in: PubMed
  152. Wessels MR, Paoletti LC, Rodewald AK, Michon F, DiFabio J, Jennings HJ, Kasper DL. Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine. Infect Immun. 1993 Nov; 61(11):4760-6.
    View in: PubMed
  153. Tzianabos AO, Onderdonk AB, Rosner B, Cisneros RL, Kasper DL. Structural features of polysaccharides that induce intra-abdominal abscesses. Science. 1993 Oct 15; 262(5132):416-9.
    View in: PubMed
  154. Pantosti A, Tzianabos AO, Reinap BG, Onderdonk AB, Kasper DL. Bacteroides fragilis strains express multiple capsular polysaccharides. J Clin Microbiol. 1993 Jul; 31(7):1850-5.
    View in: PubMed
  155. Wessels MR, Kasper DL. The changing spectrum of group B streptococcal disease. N Engl J Med. 1993 Jun 24; 328(25):1843-4.
    View in: PubMed
  156. Madoff LC, Michel JL, Gong EW, Rodewald AK, Kasper DL. Protection of neonatal mice from group B streptococcal infection by maternal immunization with beta C protein. Infect Immun. 1992 Dec; 60(12):4989-94.
    View in: PubMed
  157. Michel JL, Madoff LC, Olson K, Kling DE, Kasper DL, Ausubel FM. Large, identical, tandem repeating units in the C protein alpha antigen gene, bca, of group B streptococci. Proc Natl Acad Sci U S A. 1992 Nov 1; 89(21):10060-4.
    View in: PubMed
  158. Marques MB, Kasper DL, Pangburn MK, Wessels MR. Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci. Infect Immun. 1992 Oct; 60(10):3986-93.
    View in: PubMed
  159. Paoletti LC, Wessels MR, Michon F, DiFabio J, Jennings HJ, Kasper DL. Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine. Infect Immun. 1992 Oct; 60(10):4009-14.
    View in: PubMed
  160. Tzianabos AO, Pantosti A, Baumann H, Brisson JR, Jennings HJ, Kasper DL. The capsular polysaccharide of Bacteroides fragilis comprises two ionically linked polysaccharides. J Biol Chem. 1992 Sep 5; 267(25):18230-5.
    View in: PubMed
  161. Rodewald AK, Onderdonk AB, Warren HB, Kasper DL. Neonatal mouse model of group B streptococcal infection. J Infect Dis. 1992 Sep; 166(3):635-9.
    View in: PubMed
  162. Baumann H, Tzianabos AO, Brisson JR, Kasper DL, Jennings HJ. Structural elucidation of two capsular polysaccharides from one strain of Bacteroides fragilis using high-resolution NMR spectroscopy. Biochemistry. 1992 Apr 28; 31(16):4081-9.
    View in: PubMed
  163. Paoletti LC, Kasper DL, Michon F, DiFabio J, Jennings HJ, Tosteson TD, Wessels MR. Effects of chain length on the immunogenicity in rabbits of group B Streptococcus type III oligosaccharide-tetanus toxoid conjugates. J Clin Invest. 1992 Jan; 89(1):203-9.
    View in: PubMed
  164. Haft RF, Kasper DL. Group B streptococcus infection in mother and child. Hosp Pract (Off Ed). 1991 Dec 15; 26(12):111-22, 125-8, 133-4.
    View in: PubMed
  165. Madoff LC, Hori S, Michel JL, Baker CJ, Kasper DL. Phenotypic diversity in the alpha C protein of group B streptococci. Infect Immun. 1991 Aug; 59(8):2638-44.
    View in: PubMed
  166. Michel JL, Madoff LC, Kling DE, Kasper DL, Ausubel FM. Cloned alpha and beta C-protein antigens of group B streptococci elicit protective immunity. Infect Immun. 1991 Jun; 59(6):2023-8.
    View in: PubMed
  167. Pantosti A, Tzianabos AO, Onderdonk AB, Kasper DL. Immunochemical characterization of two surface polysaccharides of Bacteroides fragilis. Infect Immun. 1991 Jun; 59(6):2075-82.
    View in: PubMed
  168. Michon F, Chalifour R, Feldman R, Wessels M, Kasper DL, Gamian A, Pozsgay V, Jennings HJ. The alpha-L-(1----2)-trirhamnopyranoside epitope on the group-specific polysaccharide of group B streptococci. Infect Immun. 1991 May; 59(5):1690-6.
    View in: PubMed
  169. Wessels MR, DiFabio JL, Benedì VJ, Kasper DL, Michon F, Brisson JR, Jelínková J, Jennings HJ. Structural determination and immunochemical characterization of the type V group B Streptococcus capsular polysaccharide. J Biol Chem. 1991 Apr 15; 266(11):6714-9.
    View in: PubMed
  170. Tzianabos AO, Pantosti A, Baumann H, Michon F, Brisson JR, Jennings HJ, Kasper DL. Structural characterization of two surface polysaccharides of Bacteroides fragilis. Trans Assoc Am Physicians. 1991; 104:285-95.
    View in: PubMed
  171. Madoff LC, Michel JL, Kasper DL. A monoclonal antibody identifies a protective C-protein alpha-antigen epitope in group B streptococci. Infect Immun. 1991 Jan; 59(1):204-10.
    View in: PubMed
  172. Wessels MR, Kasper DL. Correct structure of repeating unit of group B Streptococcus type III capsular polysaccharide. J Infect Dis. 1990 Dec; 162(6):1412.
    View in: PubMed
  173. Wessels MR, Paoletti LC, Kasper DL, DiFabio JL, Michon F, Holme K, Jennings HJ. Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus. J Clin Invest. 1990 Nov; 86(5):1428-33.
    View in: PubMed
  174. Paoletti LC, Kasper DL, Michon F, DiFabio J, Holme K, Jennings HJ, Wessels MR. An oligosaccharide-tetanus toxoid conjugate vaccine against type III group B Streptococcus. J Biol Chem. 1990 Oct 25; 265(30):18278-83.
    View in: PubMed
  175. Rubens CE, Wessels MR, Kuypers JM, Kasper DL, Weiser JN. Molecular analysis of two group B streptococcal virulence factors. Semin Perinatol. 1990 Aug; 14(4 Suppl 1):22-9.
    View in: PubMed
  176. Baker CJ, Rench MA, Kasper DL. Response to type III polysaccharide in women whose infants have had invasive group B streptococcal infection. N Engl J Med. 1990 Jun 28; 322(26):1857-60.
    View in: PubMed
  177. Klein JO, Kass RE, Hecht RM, Stuart K, Kasper DL, Speizer FE, Majno G, Geiger J. Edward H. Kass, M.D., eulogy. J Infect Dis. 1990 Jun; 161(6):1055-8.
    View in: PubMed
  178. Klein JO, Kass RE, Hecht RM, Stuart K, Kasper DL, Speizer FE, Majno G, Geiger J. Edward H. Kass, M.D., eulogy. Rev Infect Dis. 1990 May-Jun; 12(3):375-9.
    View in: PubMed
  179. Onderdonk AB, Cisneros RL, Finberg R, Crabb JH, Kasper DL. Animal model system for studying virulence of and host response to Bacteroides fragilis. Rev Infect Dis. 1990 Jan-Feb; 12 Suppl 2:S169-77.
    View in: PubMed
  180. Crabb JH, Finberg R, Onderdonk AB, Kasper DL. T cell regulation of Bacteroides fragilis-induced intraabdominal abscesses. Rev Infect Dis. 1990 Jan-Feb; 12 Suppl 2:S178-84.
    View in: PubMed
  181. Wessels MR, Rubens CE, Benedí VJ, Kasper DL. Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule. Proc Natl Acad Sci U S A. 1989 Nov; 86(22):8983-7.
    View in: PubMed
  182. Onderdonk AB, Cisneros RL, Crabb JH, Finberg RW, Kasper DL. Intraperitoneal host cellular responses and in vivo killing of Bacteroides fragilis in a bacterial containment chamber. Infect Immun. 1989 Oct; 57(10):3030-7.
    View in: PubMed
  183. Wessels MR, Kasper DL. Antibody recognition of the type 14 pneumococcal capsule. Evidence for a conformational epitope in a neutral polysaccharide. J Exp Med. 1989 Jun 1; 169(6):2121-31.
    View in: PubMed
  184. Wessels MR, Benedí WJ, Jennings HJ, Michon F, DiFabio JL, Kasper DL. Isolation and characterization of type IV group B Streptococcus capsular polysaccharide. Infect Immun. 1989 Apr; 57(4):1089-94.
    View in: PubMed
  185. Kasper DL, Finberg RF, Crabb J, Onderdonk AB. Immune mechanisms in the prevention of intra-abdominal abscess formation. Scand J Infect Dis Suppl. 1989; 62:29-34.
    View in: PubMed
  186. Baker CJ, Rench MA, Edwards MS, Carpenter RJ, Hays BM, Kasper DL. Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus. N Engl J Med. 1988 Nov 3; 319(18):1180-5.
    View in: PubMed
  187. Michon F, Brisson JR, Dell A, Kasper DL, Jennings HJ. Multiantennary group-specific polysaccharide of group B Streptococcus. Biochemistry. 1988 Jul 12; 27(14):5341-51.
    View in: PubMed
  188. Breeling JL, Onderdonk AB, Cisneros RL, Kasper DL. Bacteroides vulgatus outer membrane antigens associated with carrageenan-induced colitis in guinea pigs. Infect Immun. 1988 Jul; 56(7):1754-9.
    View in: PubMed
  189. Kasper DL, Zaleznik DF. Diagnosis of pancreatic infection. Gastroenterology. 1988 May; 94(5 Pt 1):1244-5.
    View in: PubMed
  190. Wessels MR, Muñoz A, Kasper DL. A model of high-affinity antibody binding to type III group B Streptococcus capsular polysaccharide. Proc Natl Acad Sci U S A. 1987 Dec; 84(24):9170-4.
    View in: PubMed
  191. Rubens CE, Wessels MR, Heggen LM, Kasper DL. Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence. Proc Natl Acad Sci U S A. 1987 Oct; 84(20):7208-12.
    View in: PubMed
  192. Wessels MR, Pozsgay V, Kasper DL, Jennings HJ. Structure and immunochemistry of an oligosaccharide repeating unit of the capsular polysaccharide of type III group B Streptococcus. A revised structure for the type III group B streptococcal polysaccharide antigen. J Biol Chem. 1987 Jun 15; 262(17):8262-7.
    View in: PubMed
  193. Christou NV, Mannick JA, West MA, Kasper DL. Lymphocyte macrophage interactions in the response to surgical infections. Arch Surg. 1987 Feb; 122(2):239-51.
    View in: PubMed
  194. Michon F, Katzenellenbogen E, Kasper DL, Jennings HJ. Structure of the complex group-specific polysaccharide of group B Streptococcus. Biochemistry. 1987 Jan 27; 26(2):476-86.
    View in: PubMed
  195. Pozsgay V, Jennings H, Kasper DL. 4,8-anhydro-N-acetylneuraminic acid. Isolation from edible bird's nest and structure determination. Eur J Biochem. 1987 Jan 15; 162(2):445-50.
    View in: PubMed
  196. Zaleznik DF, Zhang ZL, Onderdonk AB, Kasper DL. Effect of subinhibitory doses of clindamycin on the virulence of Bacteroides fragilis: role of lipopolysaccharide. J Infect Dis. 1986 Jul; 154(1):40-6.
    View in: PubMed
  197. Shapiro ME, Kasper DL, Zaleznik DF, Spriggs S, Onderdonk AB, Finberg RW. Cellular control of abscess formation: role of T cells in the regulation of abscesses formed in response to Bacteroides fragilis. J Immunol. 1986 Jul 1; 137(1):341-6.
    View in: PubMed
  198. Baker CJ, Webb BJ, Kasper DL, Edwards MS. The role of complement and antibody in opsonophagocytosis of type II group B streptococci. J Infect Dis. 1986 Jul; 154(1):47-54.
    View in: PubMed
  199. Levy NJ, Kasper DL. Surface-bound capsular polysaccharide of type Ia group B Streptococcus mediates C1 binding and activation of the classic complement pathway. J Immunol. 1986 Jun 1; 136(11):4157-62.
    View in: PubMed
  200. Valtonen MV, Kasper DL, Levy NJ. Isolation of a C (Ibc) protein from group B Streptococcus which elicits mouse protective antibody. Microb Pathog. 1986 Apr; 1(2):191-204.
    View in: PubMed
  201. Kasper DL. Bacterial capsule--old dogmas and new tricks. J Infect Dis. 1986 Mar; 153(3):407-15.
    View in: PubMed
  202. Schifferle RE, Jennings HJ, Wessels MR, Katzenellenbogen E, Roy R, Kasper DL. Immunochemical analysis of the types Ia and Ib group B streptococcal polysaccharides. J Immunol. 1985 Dec; 135(6):4164-70.
    View in: PubMed
  203. Levy NJ, Kasper DL. Antibody-independent and -dependent opsonization of group B Streptococcus requires the first component of complement C1. Infect Immun. 1985 Jul; 49(1):19-24.
    View in: PubMed
  204. Baker CJ, Kasper DL. Group B streptococcal vaccines. Rev Infect Dis. 1985 Jul-Aug; 7(4):458-67.
    View in: PubMed
  205. Zaleznik DF, Finberg RW, Shapiro ME, Onderdonk AB, Kasper DL. A soluble suppressor T cell factor protects against experimental intraabdominal abscesses. J Clin Invest. 1985 Mar; 75(3):1023-7.
    View in: PubMed
  206. Wessels MR, Kasper DL. Molecular size affects antigenicity of type III, group B Streptococcus capsular polysaccharide. Trans Assoc Am Physicians. 1985; 98:384-91.
    View in: PubMed
  207. Baker CJ, Kasper DL. Vaccination as a measure for prevention of neonatal GBS infection. Antibiot Chemother. 1985; 35:281-90.
    View in: PubMed
  208. Edwards MS, Kasper DL, Nicholson-Weller A, Baker CJ. The role of complement in opsonization of GBS. Antibiot Chemother. 1985; 35:170-89.
    View in: PubMed
  209. Kasper DL, Baker CJ, Jennings HJ. Cell structure and antigenic composition of GBS. Antibiot Chemother. 1985; 35:90-100.
    View in: PubMed
  210. Levy NJ, Nicholson-Weller A, Baker CJ, Kasper DL. Potentiation of virulence by group B streptococcal polysaccharides. J Infect Dis. 1984 Jun; 149(6):851-60.
    View in: PubMed
  211. Edwards MS, Fuselier PA, Rench MA, Kasper DL, Baker CJ. Class specificity of naturally acquired and vaccine-induced antibody to type III group B streptococcal capsular polysaccharide: determination with a radioimmunoprecipitin assay. Infect Immun. 1984 May; 44(2):257-61.
    View in: PubMed
  212. Pandey JP, Baker CJ, Kasper DL, Fudenberg HH. Two unlinked genetic loci interact to control the human immune response to type III group B streptococcal antigen. J Immunogenet. 1984 Apr; 11(2):159-63.
    View in: PubMed
  213. Onderdonk AB, Shapiro ME, Finberg RW, Zaleznik DF, Kasper DL. Use of a model of intraabdominal sepsis for studies of the pathogenicity of Bacteroides fragilis. Rev Infect Dis. 1984 Mar-Apr; 6 Suppl 1:S91-5.
    View in: PubMed
  214. Kasper DL, Lindberg AA, Weintraub A, Onderdonk AB, Lönngren J. Capsular polysaccharides and lipopolysaccharides from two strains of Bacteroides fragilis. Rev Infect Dis. 1984 Mar-Apr; 6 Suppl 1:S25-9.
    View in: PubMed
  215. Wade BH, Kasper DL, Mandell GL. Interactions of Bacteroides fragilis and phagocytes: studies with whole organisms, purified capsular polysaccharide and clindamycin-treated bacteria. J Antimicrob Chemother. 1983 Oct; 12 Suppl C:51-62.
    View in: PubMed
  216. Larsen JW, Harper JS, London WT, Baker CJ, Curfman BL, Kasper DL, Sever JL. Antibody to type III group B Streptococcus in the rhesus monkey. Am J Obstet Gynecol. 1983 Aug 15; 146(8):958-62.
    View in: PubMed
  217. Kasper DL, Baker CJ, Galdes B, Katzenellenbogen E, Jennings HJ. Immunochemical analysis and immunogenicity of the type II group B streptococcal capsular polysaccharide. J Clin Invest. 1983 Jul; 72(1):260-9.
    View in: PubMed
  218. Weintraub A, Lindberg AA, Kasper DL. Characterization of Bacteroides fragilis strains based on antigen-specific immunofluorescence. J Infect Dis. 1983 Apr; 147(4):780.
    View in: PubMed
  219. Weiss M, Ingbar SH, Winblad S, Kasper DL. Demonstration of a saturable binding site for thyrotropin in Yersinia enterocolitica. Science. 1983 Mar 18; 219(4590):1331-3.
    View in: PubMed
  220. Jennings HJ, Katzenellenbogen E, Lugowski C, Kasper DL. Structure of native polysaccharide antigens of type Ia and type Ib group B Streptococcus. Biochemistry. 1983 Mar 1; 22(5):1258-64.
    View in: PubMed
  221. Shapiro ME, Onderdonk AB, Kasper DL, Finberg RW. Immune T cells prevent bacteroides fragilis abscesses. Curr Surg. 1983 Mar-Apr; 40(2):123-6.
    View in: PubMed
  222. Jennings HJ, Rosell KG, Katzenellenbogen E, Kasper DL. Structural determination of the capsular polysaccharide antigen of type II group B Streptococcus. J Biol Chem. 1983 Feb 10; 258(3):1793-8.
    View in: PubMed
  223. Kasper DL, Weintraub A, Lindberg AA, Lönngren J. Capsular polysaccharides and lipopolysaccharides from two Bacteroides fragilis reference strains: chemical and immunochemical characterization. J Bacteriol. 1983 Feb; 153(2):991-7.
    View in: PubMed
  224. Eads ME, Levy NJ, Kasper DL, Baker CJ, Nicholson-Weller A. Antibody-independent activation of C1 by type Ia group B streptococci. J Infect Dis. 1982 Nov; 146(5):665-72.
    View in: PubMed
  225. Tabaqchali S, Fiddian PA, El-Hag K, Kasper DL. Capsular and 'O' serotype determinants of bacteroides fragilis. Infection. 1982 Nov-Dec; 10(6):333-7.
    View in: PubMed
  226. Rice PA, Kasper DL. Characterization of serum resistance of Neisseria gonorrhoeae that disseminate. Roles of blocking antibody and gonococcal outer membrane proteins. J Clin Invest. 1982 Jul; 70(1):157-67.
    View in: PubMed
  227. Polin RA, Douglas SD, Kasper DL, Baker CJ. Enzyme-linked immunosorbent assay for measurement of antibody to type III group B streptococci. J Clin Microbiol. 1982 Jun; 15(6):991-3.
    View in: PubMed
  228. Markham RB, Nicholson-Weller A, Schiffman G, Kasper DL. The presence of sialic acid on two related bacterial polysaccharides determines the site of the primary immune response and the effect of complement depletion on the response in mice. J Immunol. 1982 Jun; 128(6):2731-3.
    View in: PubMed
  229. Joiner KA, McAdam KP, Kasper DL. Lipopolysaccharides from Bacteroides fragilis are mitogenic for spleen cells from endotoxin responder and nonresponder mice. Infect Immun. 1982 Jun; 36(3):1139-45.
    View in: PubMed
  230. Shapiro ME, Onderdonk AB, Kasper DL, Finberg RW. Cellular immunity to Bacteroides fragilis capsular polysaccharide. J Exp Med. 1982 Apr 1; 155(4):1188-97.
    View in: PubMed
  231. Edwards MS, Kasper DL, Jennings HJ, Baker CJ, Nicholson-Weller A. Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci. J Immunol. 1982 Mar; 128(3):1278-83.
    View in: PubMed
  232. Flesher AR, Jennings HJ, Lugowski C, Kasper DL. Isolation of a serogroup 1-specific antigen from Legionella pneumophila. J Infect Dis. 1982 Feb; 145(2):224-33.
    View in: PubMed
  233. Baker CJ, Edwards MS, Webb BJ, Kasper DL. Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus. J Clin Invest. 1982 Feb; 69(2):394-404.
    View in: PubMed
  234. Onderdonk AB, Markham RB, Zaleznik DF, Cisneros RL, Kasper DL. Evidence for T cell-dependent immunity to Bacteroides fragilis in an intraabdominal abscess model. J Clin Invest. 1982 Jan; 69(1):9-16.
    View in: PubMed
  235. Lindberg AA, Weintraub A, Kasper DL, Lönngren J. Virulence factors in infections with bacteroides fragilis: isolation and characterization of capsular polysaccharide and lipopolysaccharide. Scand J Infect Dis Suppl. 1982; 35:45-52.
    View in: PubMed
  236. Simon GL, Klempner MS, Kasper DL, Gorbach SL. Alterations in opsonophagocytic killing by neutrophils of Bacteroides fragilis associated with animal and laboratory passage: effect of capsular polysaccharide. J Infect Dis. 1982 Jan; 145(1):72-7.
    View in: PubMed
  237. Kasper DL, Onderdonk AB. Infection with Bacteroides fragilis: pathogenesis and immunoprophylaxis in an animal model. Scand J Infect Dis Suppl. 1982; 31:28-33.
    View in: PubMed
  238. Zaleznik DF, Kasper DL. The role of anaerobic bacteria in abscess formation. Annu Rev Med. 1982; 33:217-29.
    View in: PubMed
  239. Webb BJ, Kasper DL, Baker CJ. Lack of stimulation of isohemagglutinin antibodies by immunization with group B streptococcal (type III) vaccine. J Pediatr. 1981 Dec; 99(6):918-20.
    View in: PubMed
  240. Baker CJ, Edwards MS, Kasper DL. Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection. Pediatrics. 1981 Oct; 68(4):544-9.
    View in: PubMed
  241. Jennings HJ, Lugowski C, Kasper DL. Conformational aspects critical to the immunospecificity of the type III group B streptococcal polysaccharide. Biochemistry. 1981 Aug 4; 20(16):4511-8.
    View in: PubMed
  242. Baltimore RS, Baker CJ, Kasper DL. Antibody to group B Streptococcus type III in human sera measured by a mouse protection test. Infect Immun. 1981 Apr; 32(1):56-61.
    View in: PubMed
  243. Paavonen J, Valtonen VV, Kasper DL, Malkamäki M, Mäkelä PH. Serological evidence for the role of Bacteroides fragilis and enterobacteriaceae in the pathogenesis of acute pelvic inflammatory disease. Lancet. 1981 Feb 7; 1(8215):293-5.
    View in: PubMed
  244. Kasper DL, Onderdonk AB, Reinap BG, Linberg AA. Variations of Bacteroides fragilis with in vitro passage: presence of an outer membrane-associated glycan and loss of capsular antigen. J Infect Dis. 1980 Nov; 142(5):750-6.
    View in: PubMed
  245. Shurin PA, Pelton SI, Tager IB, Kasper DL. Bactericidal antibody and susceptibility to otitis media caused by nontypable strains of Haemophilus influenzae. J Pediatr. 1980 Sep; 97(3):364-9.
    View in: PubMed
  246. Flesher AR, Kasper DL, Modern PA, Mason EO. Legionella pneumophila: growth inhibition by human pharyngeal flora. J Infect Dis. 1980 Sep; 142(3):313-7.
    View in: PubMed
  247. Baker CJ, Kasper DL, Edwards MS, Schiffman G. Influence of preimmunization antibody levels on the specificity of the immune response to related polysaccharide antigens. N Engl J Med. 1980 Jul 24; 303(4):173-8.
    View in: PubMed
  248. Baker CJ, Webb BJ, Kasper DL, Yow MD, Beachler CW. The natural history of group B streptococcal colonization in the pregnant woman and her offspring. II. Determination of serum antibody to capsular polysaccharide from type III, group B Streptococcus. Am J Obstet Gynecol. 1980 May 1; 137(1):39-42.
    View in: PubMed
  249. Rice PA, McCormack WM, Kasper DL. Natural serum bactericidal activity against Neisseria gonorrhoeae isolates from disseminated, locally invasive, and uncomplicated disease. J Immunol. 1980 May; 124(5):2105-9.
    View in: PubMed
  250. Jennings HJ, Rosell KG, Kasper DL. Structure and serology of the native polysaccharide antigen of type Ia group B streptococcus. Proc Natl Acad Sci U S A. 1980 May; 77(5):2931-5.
    View in: PubMed
  251. Edwards MS, Nicholson-Weller A, Baker CJ, Kasper DL. The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B Streptococcus. J Exp Med. 1980 May 1; 151(5):1275-87.
    View in: PubMed
  252. Vogel LC, Boyer KM, Gotoff SP, Kasper DL, Baker CJ. Comparison of assays for antibody to group B Streptococcus, type III. J Infect Dis. 1980 Apr; 141(4):530.
    View in: PubMed
  253. Polk BF, Kasper DL, Shapiro M, Tager IB, Schoenbaum SC, Goldstein PR. Serum antibody response to Bacteroides fragilis in women with abscesses following hysterectomy. Obstet Gynecol. 1980 Feb; 55(2):163-6.
    View in: PubMed
  254. Jennings HJ, Rosell KG, Kasper DL. Structural determination and serology of the native polysaccharide antigen of type-III group B Streptococcus. Can J Biochem. 1980 Feb; 58(2):112-20.
    View in: PubMed
  255. Edwards MS, Baker CJ, Kasper DL. Opsonic specificity of human antibody to the type III polysaccharide of group B Streptococcus. J Infect Dis. 1979 Dec; 140(6):1004-8.
    View in: PubMed
  256. Mansheim BJ, Kasper DL. Detection of anticapsular antibodies to Bacteroides asaccharolyticus in serum from rabbits and humans by use of an enzyme-linked immunosorbent assay. J Infect Dis. 1979 Dec; 140(6):945-51.
    View in: PubMed
  257. Kasper DL, Onderdonk AB, Crabb J, Bartlett JG. Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis. J Infect Dis. 1979 Nov; 140(5):724-31.
    View in: PubMed
  258. Edwards MS, Kasper DL, Baker CJ. Rapid diagnosis of type III group B streptococcal meningitis by latex particle agglutination. J Pediatr. 1979 Aug; 95(2):202-5.
    View in: PubMed
  259. Baltimore RS, Kasper DL, Vecchitto J. Mouse protection test for group B Streptococcus type III. J Infect Dis. 1979 Jul; 140(1):81-8.
    View in: PubMed
  260. Flesher AR, Ito S, Mansheim BJ, Kasper DL. The cell envelope of the Legionnaires' disease bacterium. Morphologic and biochemical characteristics. Ann Intern Med. 1979 Apr; 90(4):628-30.
    View in: PubMed
  261. Onderdonk AB, Kasper DL, Mansheim BJ, Louie TJ, Gorbach SL, Bartlett JG. Experimental animal models for anaerobic infections. Rev Infect Dis. 1979 Mar-Apr; 1(2):291-301.
    View in: PubMed
  262. Mansheim BJ, Onderdonk AB, Kasper DL. Immunochemical characterization of surface antigens of Bacteroides melaninogenicus. Rev Infect Dis. 1979 Mar-Apr; 1(2):263-77.
    View in: PubMed
  263. Kasper DL. Virulence factors of anaerobic bacteria: an overview. Rev Infect Dis. 1979 Mar-Apr; 1(2):246-7.
    View in: PubMed
  264. Kasper DL, Onderdonk AB, Polk BF, Bartlett JG. Surface antigens as virulence factors in infection with Bacteroides fragilis. Rev Infect Dis. 1979 Mar-Apr; 1(2):278-90.
    View in: PubMed
  265. Kasper DL, Fiddian AP, Tabaqchali S. Rapid diagnosis of Bacteroides infections by indirect immunofluorescence assay of clinical specimens. Lancet. 1979 Feb 3; 1(8110):239-42.
    View in: PubMed
  266. Kasper DL, Baker CJ, Baltimore RS, Crabb JH, Schiffman G, Jennings HJ. Immunodeterminant specificity of human immunity to type III group B streptococcus. J Exp Med. 1979 Feb 1; 149(2):327-39.
    View in: PubMed
  267. Kasper DL, Baker CJ. Electron microscopic definition of surface antigens of group B Streptococcus. J Infect Dis. 1979 Feb; 139(2):147-51.
    View in: PubMed
  268. Beachler CW, Baker CJ, Kasper DL, Fleming DK, Webb BJ, Yow MD. Group B streptococcal colonization and antibody status in lower socioeconomic parturient women. Am J Obstet Gynecol. 1979 Jan 15; 133(2):171-3.
    View in: PubMed
  269. Mansheim BJ, Solstad CA, Kasper DL. Identification of a subspecies-specific capsular antigen from Bacteroides melaninogenicus subspecies asaccharolyticus by immunofluorescence and electron microscopy. J Infect Dis. 1978 Dec; 138(6):736-41.
    View in: PubMed
  270. Kasper DL, Goroff DK, Baker CJ. Immunochemical characterization of native polysaccharides from group B streptococcus: the relationship of the type III and group B determinants. J Immunol. 1978 Sep; 121(3):1096-105.
    View in: PubMed
  271. Bartlett JG, Onderdonk AB, Louie T, Kasper DL, Gorbach SL. A review. Lessons from an animal model of intra-abdominal sepsis. Arch Surg. 1978 Jul; 113(7):853-7.
    View in: PubMed
  272. Kasper DL, Eschenbach DA, Hayes ME, Holmes KK. Quantitative determination of the serum antibody response to the capsular polysaccharide of Bacteroides fragilis subspecies fragilis in women with pelvic inflammatory disease. J Infect Dis. 1978 Jul; 138(1):74-80.
    View in: PubMed
  273. Baker CJ, Edwards MS, Kasper DL. Immunogenicity of polysaccharides from type III, group B Streptococcus. J Clin Invest. 1978 Apr; 61(4):1107-10.
    View in: PubMed
  274. Onderdonk AB, Moon NE, Kasper DL, Bartlett JG. Adherence of Bacteroides fragilis in vivo. Infect Immun. 1978 Mar; 19(3):1083-7.
    View in: PubMed
  275. Mansheim BJ, Onderdonk AB, Kasper DL. Immunochemical and biologic studies of the lipopolysaccharide of Bacteroides melaninogenicus subspecies asaccharolyticus. J Immunol. 1978 Jan; 120(1):72-8.
    View in: PubMed
  276. Kasper DL, Onderdonk AB, Bartlett JG. Quantitative determination of the antibody response to the capsular polysaccharide of Bacteroides fragilis in an animal model of intraabdominal abscess formation. J Infect Dis. 1977 Dec; 136(6):789-95.
    View in: PubMed
  277. Rice PA, Kasper DL. Characterization of gonococcal antigens responsible for induction of bactericidal antibody in disseminated infection. J Clin Invest. 1977 Nov; 60(5):1149-58.
    View in: PubMed
  278. Bartlett JG, Onderdonk AB, Cisneros RL, Kasper DL. Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J Infect Dis. 1977 Nov; 136(5):701-5.
    View in: PubMed
  279. Hammerschlag MR, Baker CJ, Alpert S, Kasper DL, Rosner I, Thurston P, Webb BJ, McCormack WM. Colonization with group B streptococci in girls under 16 years of age. Pediatrics. 1977 Oct; 60(4):473-6.
    View in: PubMed
  280. Baker CJ, Kasper DL. Immunological investigation of infants with septicemia or meningitis due to group B Streptococcus. J Infect Dis. 1977 Aug; 136 Suppl:S98-104.
    View in: PubMed
  281. Kasper DL, Hayes ME, Reinap BG, Craft FO, Onderdonk AB, Polk BF. Isolation and identification of encapsulated strains of Bacteroides fragilis. J Infect Dis. 1977 Jul; 136(1):75-81.
    View in: PubMed
  282. Onderdonk AB, Kasper DL, Cisneros RL, Bartlett JG. The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains. J Infect Dis. 1977 Jul; 136(1):82-9.
    View in: PubMed
  283. Baker CJ, Kasper DL, Paredes A, Alpert S, McCormack WM, Goroff D. Quantitative determination of antibody to capsular polysaccharide in infection with type III strains of group B Streptococcus. J Clin Invest. 1977 May; 59(5):810-8.
    View in: PubMed
  284. Mansheim BJ, Kasper DL. Purification and immunochemical characterization of the outer membrane complex of Bacteroides melaninogenicus subspecies asaccharolyticus. J Infect Dis. 1977 May; 135(5):787-99.
    View in: PubMed
  285. Polk BF, Kasper DL. Bacteroides fragilis subspecies in clinical isolates. Ann Intern Med. 1977 May; 86(5):569-71.
    View in: PubMed
  286. Kasper DL, Rice PA, McCormick WM. Bactericidal antibody in genital infection due to Neisseria gonorrhoeae. J Infect Dis. 1977 Feb; 135(2):243-51.
    View in: PubMed
  287. Baltimore RS, Kasper DL, Baker CJ, Goroff DK. Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci. J Immunol. 1977 Feb; 118(2):673-8.
    View in: PubMed
  288. Kasper DL. Chemical and biological characterization of the lipopolysaccharide of Bacteroides fragilis subspecies fragilis. J Infect Dis. 1976 Jul; 134(1):59-66.
    View in: PubMed
  289. Baker CJ, Kasper DL. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med. 1976 Apr 1; 294(14):753-6.
    View in: PubMed
  290. Baker CJ, Kasper DL, Davis CE. Immunochemical characterization of the "native" type III polysaccharide of group B Streptococcus. J Exp Med. 1976 Feb 1; 143(2):258-70.
    View in: PubMed
  291. Baker CJ, Kasper DL. Identification of sialic acid in polysaccharide antigens in group B Streptococcus. Infect Immun. 1976 Jan; 13(1):284-8.
    View in: PubMed
  292. Kasper DL. The polysaccharide capsule of Bacteroides fragilis subspecies fragilis: immunochemical and morphologic definition. J Infect Dis. 1976 Jan; 133(1):79-87.
    View in: PubMed
  293. Baker CJ, Kasper DL. Microcapsule of type III strains of group B Streptococcus: production and morphology. Infect Immun. 1976 Jan; 13(1):189-94.
    View in: PubMed
  294. Kasper DL, Seiler MW. Immunochemical characterization of the outer membrane complex of Bacteroides fragilis subspecies fragilis. J Infect Dis. 1975 Oct; 132(4):440-50.
    View in: PubMed
  295. Kasper DL, Winkelhake JL, Brandt BL, Artenstein MS. Antigenic specificity of bactericidal antibodies in antisera to Neisseria meningitidis. J Infect Dis. 1973 Apr; 127(4):378-87.
    View in: PubMed
  296. Kasper DL, Winkelhake JL, Zollinger WD, Brandt BL, Artenstein MS. Immunochemical similarity between polysaccharide antigens of Escherichia coli 07: K1(L):NM and group B Neisseria meningitidis. J Immunol. 1973 Jan; 110(1):262-8.
    View in: PubMed
  297. Zollinger WD, Kasper DL, Veltri BJ, Artenstein MS. Isolation and characterization of a native cell wall complex from Neisseria meningitidis. Infect Immun. 1972 Nov; 6(5):835-51.
    View in: PubMed
  298. Wyle FA, Artenstein MS, Brandt BL, Tramont EC, Kasper DL, Altieri PL, Berman SL, Lowenthal JP. Immunologic response of man to group B meningococcal polysaccharide vaccines. J Infect Dis. 1972 Nov; 126(5):514-21.
    View in: PubMed
  299. Winkelhake JL, Kasper DL. Affinity chromatography of anti-meningococcal antiserum. J Immunol. 1972 Oct; 109(4):824-33.
    View in: PubMed
  300. Kasper DL, Wyle FA, Formal SB. Bactericidal antibody assay using 14 C-labeled Neisseria meningitidis. Proc Soc Exp Biol Med. 1972 Apr; 139(4):1175-80.
    View in: PubMed
  301. Artenstein MS, Branche WC, Zimmerly JG, Cohen RL, Tramont EC, Kasper DL, Harkins C. Meningococcal infections. 3. Studies of group A polysaccharide vaccines. Bull World Health Organ. 1971; 45(3):283-6.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Kasper's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_